PROCESSA PHARMACEUTICALS, INC.

Calendar Processa Pharmaceuticals, Inc.

Stocks

PCSA

US74275C4033

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
2.060 ^USD	+0.49%		+0.49%	-28.47%

08-14	Processa Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Processa Pharmaceuticals, Inc. announced that it has received $200 million in funding from a group of investors	CI

Chart calendar Processa Pharmaceuticals, Inc.

1b7cfe5c9220b901b.0IJH4Ve-2askgcYCpnIqlSnm1REHL0Jw4cPKGaOXCXU.peMzhBrMvdNCyI1s3ChArGyE4kNhfHMz04ike8akfEL9zD-MOMuR7HPUrQ~931b0bb40cdfc8656157491a9395620d

Upcoming events on Processa Pharmaceuticals, Inc.

No events available

Past events on Processa Pharmaceuticals, Inc.

2026-07-30	Annual General Meeting	13:00
2025-09-10	Extraordinary General Meeting

Past dividends on Processa Pharmaceuticals, Inc.

2025-12-17

Significant Split/Dividend

00:00

Annual results

Fiscal Period	December	2023	2024
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	-11,5 -11,2 -2.63%	-12,1 -12,4 2.55%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-11,1 -10,9 -2.1%	-11,9 -12,2 2.48%
Net income Million USD	Released Forecast Spread	-11,1 -10,9 -2.1%	-11,9 -12,2 2.48%
EPS USD	Released Forecast Spread	-212 -213 0.24%	-96,8 -101 4.44%
Announcement Date		29/03/24	20/03/25

Quarterly results

Fiscal Period	June	2024 Q4	2025 Q1	2025 Q2	2025 Q3
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	-2,73 -3,05 10.34%	-2,85 -2,60 -9.58%	-3,95 -2,68 -47.2%	-3,49 -3,87 9.73%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-2,73 -3,03 9.94%	-2,83 -2,60 -9.1%	-3,93 -2,68 -46.73%	-3,44 -3,86 10.99%
Net income Million USD	Released Forecast Spread	-2,73 -3,03 9.94%	-2,83 -2,60 -9.1%	-3,93 -2,68 -46.73%	-3,44 -3,86 10.99%
EPS USD	Released Forecast Spread	-18,5 -23,0 19.57%	-7,50 -12,3 38.78%	-6,25 -5,50 -13.64%	-1,75 -2,00 12.5%
Announcement Date		20/03/25	08/05/25	07/08/25	06/11/25

Upcoming sector events for Processa Pharmaceuticals, Inc.

2026-09-08	XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD	Extraordinary General Meeting	23:00
2026-09-09	TYRA BIOSCIENCES, INC.	Information meeting	08:00
2026-09-10	LONGBIO PHARMA (SUZHOU) CO., LTD.	Extraordinary General Meeting	04:00
2026-09-16	ARGENX SE	Extraordinary General Meeting
2026-09-16	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.	Earnings presentation	03:00
2026-09-16	ABBISKO CAYMAN LIMITED	Extraordinary General Meeting	22:00
2026-09-16	ABBISKO CAYMAN LIMITED	Présentation aux Actionnaires / Analystes	22:00
2026-09-17	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.	Extraordinary General Meeting	03:00
2026-09-21	CYBIN INC.	Annual General Meeting
2026-09-22	HITGEN INC.	Earnings presentation	01:00

Past sector events for Processa Pharmaceuticals, Inc.

Today	RZNOMICS INC.	Présentation aux Actionnaires / Analystes	02:00
2026-09-04	WUXI APPTEC CO., LTD.	Ex-dividend date - 0.51 CNY	00:00
2026-09-04	XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD	Earnings presentation	01:00
2026-09-03	CLIMB BIO, INC.	Information meeting	08:00
2026-09-02	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	Ex-dividend date - 0.6 CNY	00:00
2026-09-02	BELITE BIO, INC	Information meeting	08:00
2026-09-01	INVENTISBIO CO., LIMITED	Earnings presentation	22:00
2026-09-01	ALUMIS INC.	Information meeting	08:30
2026-08-31	ARROWHEAD PHARMACEUTICALS, INC.	Information meeting	08:00
2026-08-31	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.	Earnings release - Q2 2026

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

Stock Market
Stocks
PCSA Stock
Calendar Processa Pharmaceuticals, Inc.

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!